If this BS stock gets anywhere near the 6M Outstanding Shares as you suggest, the math says you're now Burnt Toast. You're talking about nearly 4X dilution from here + matching warrants. There's barely any meat left on the bone already for pre-split shareholders, but I surmise Moreau's reorganization plan doesn't account for that. Why would it? He, along with the others @ HQ have very little skin in the game. Either way, I'm seeing a very shaky start to 2022. Yet again, the CEO blows smoke up our butts with all his pie in the sky timelines and likely none of them will come to fruition as laid out. Last thing, as the calendar is set for the Phase 1's, I see no path where Algernon will get to a Phase 2 ("Everybody Wants In At Phase 2" - Moreau) data readout before 2H 2024. 2025 if Moreau returns to Australia for any of the clinical trials Moreau can do a lot more damage between now and then in whatever insane way we have yet to encounter. Moreau is a Magician @ messing shit up. Thanks for your opinion. It's good to see someone else is still out there.
Oh, the hiring of the old Chairman Of The Board from XORTX is one to follow. Yeah, XORTX uplifted to Nasdaq but look at it's performance. It's a friggin 1 dollar stock with a BS market cap. That's the type of shit Moreau holds up as being successful. IMO, Moreau is a small time operator. He's never been as far as he's gotten prior to King Cobra appointing him to the job. In all of Moreau's time before Algernon. Moreau raised a total of 30 Million dollars. Moreau now sits in a chair that gives him the opportunity to raise 50 Million dollars and surely he's salivating over how much of that he can get ASAP. With his fire sale track record I don't think for one second he would care about the share price once uplisted, if ever. Just delay delay delay dilute.
peace,
M$
News 
Market Data 
Discover 
